[Editor’s note: This article was updated on 7 April to clarify the regulatory status of the Becton Dickinson/BioMedomics serology COVID-19 test and update the status of the BioGx's rapid COVID-19 test, which runs on Becton Dickinson's automated system.]
Becton Dickinson & Co. is launching a rapid point-of-care serology COVID-19 test developed and manufactured by North Carolina-based BioMedomics, the companies announced on 31 March.